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Recent interest in the early course of schizophrenia accentuated altered cognition prior to the onset. Ultrahigh risk (UHR) indi-
viduals with attenuated positive symptoms and transient psychotic episodes demonstrate neurocognitive deficits across multiple
domains such as memory, executive functioning, and processing speed which are consistent with similar disturbances identified in
patientswith a first episode of schizophrenia. Cognitive remediation (CR) approaches representing a broad set of activities are aimed
to restore or improve cognitive functioning. CR proved to be effective in modulating the cognitive dysfunction in schizophrenia
but is rarely used in ultrahigh risk individuals. From the clinical prospective, a better understanding of cognitive functioning in
at-risk states is essential for the development of optimal early intervention models. In the review, we highlight the intervention
targets, notably the specific cognitive deficits in at risk individuals which preceed the transition to psychosis and emphasize the
need of the additional studies using CR approaches in UHR group aiming to enhance cognition and therefore mediate functional
improvement.
1. Neurocognitive Deficits in Schizophrenia
Since the earliest description of schizophrenia, cognitive
dysfunction has been noted as a core component of the illness
[1]. At present, it is well established that individuals with
schizophrenia demonstrate significant impairments across a
broad range of cognitive domains, including memory, execu-
tive functions, attention,motor abilities, and spatial functions
[2], in first episode patients [3, 4] and in their unaffected
relatives [5, 6]. While the early studies reported “generalized”
cognitive deficits in schizophrenia [7, 8], others underlined
the “selectivity of dysfunction” in specific cognitive domains:
memory [9, 10] and executive functioning [11, 12].The overall
impairment profile of individuals with schizophrenia suppos-
edly represents the disruption of fundamental neural circuits
encompassing cortical-cerebellar-thalamic-cortical subsys-
tems [13]. Thus, many researchers proposed cognitive dys-
function as a potential endophenotype in schizophrenia due
to their detection across schizophrenia spectrum groups [14,
15], high test-retest reliability [16, 17], and heritability [18].
In the last decade, there has been an increasing interest in
cognitive disturbances in the early course of schizophrenia.
While the neuropsychological deficits tend to be fairly stable
in chronic schizophrenia [16, 19], it has been suggested
that there might be more amenable changes during the
prodromal period and shortly after the illness onset. A large
retrospective study demonstrated impairment of cognition
to be among the “first signs” in individuals who were later
diagnosed with schizophrenia [20].The presence of cognitive
impairment prior to the onset of psychosis and early after its
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manifestation suggests that some neurocognitive abnormal-
ities precede and are not solely a consequence of psychosis
and thus may represent a trait marker for schizophrenia.
Understanding the trajectory of cognitive changes in the
development of schizophrenia may shed some light on the
neurodevelopmental processes happening at the initial stages
of the illness.
The staging model of schizophrenia defines the course
of schizophrenia with regard to the clinical and functional
level of deterioration and underlines the predictive validity of
early and latter brain alterations [21–23]. Psychophysiological
data largely drawn from neuroimaging studies differentiate
between three major clinical stages which describe the brain
volume changes over the course of the illness: ultrahigh risk
stage (UHR) for psychosis or prepsychotic phasewhen people
present with potentially prodromal symptoms, first episode
or manifestation of psychosis and chronic schizophre-
nia. Specifically, the loss of grey matter in the prefrontal cor-
tex, lateral temporal and medial temporal regions, superior
temporal gyrus, and insula as well as the white matter
abnormalities in the fronto-occipital fasciculus predicts the
transition from ultrahigh risk to full-blown psychosis [24–
27]. Consistent with the staging model, there has been an
increasing body of evidence of persisting cognitive abnormal-
ities in the early stages of schizophrenia: starting presumably
in the prodromal phase, deteriorating and reaching the
peak at the manifestation of the first psychotic episode, and
remaining relatively stable at the course of schizophrenia [28].
However, the time course of the emergence of neurocognitive
deficits is not well understood. Subtle cognitive deficits in
workingmemory, attention, and processing speed are already
detected in individuals with family risk for psychosis [29, 30]
and children who developed adult schizophrenia [31]; these
cognitive domains are predisposed to further deterioration
[32]. Therefore, cognitive impairments in genetic high-risk
subjects that are not confounded by psychosis or medications
provide a strong support for a neurodevelopmental model of
prepsychotic vulnerability for schizophrenia [32].
2. Cognitive Dysfunction in
Ultrahigh Risk Individuals
The ultrahigh risk (UHR) status is characterised by subjec-
tively experiencing disturbances in perception, thought pro-
cessing, language, brief psychotic episodes that are distinct
from classic psychotic symptoms, independent of abnormal
thought content, and intact in reality testing and insight.
UHR criteria include attenuated positive symptoms or brief
limited intermittent psychotic symptoms and genetic risk
[33]. The presence of at least one fully positive psychotic
symptom several times per week for at least one month or at
least one fully psychotic symptom for at least one day if this
symptom is seriously disorganizing or dangerous constitutes
the transition to psychosis criteria [33]. Individuals who
meet the UHR criteria have a transition rate to psychosis of
approximately 30–35% within a follow-up period of 1–3 years
[34, 35].
Several studies have reported deficits in multiple cogni-
tive domains in UHR samples, as compared to the general
normal population, with the most pronounced impairments
being of rapid information processing, including visual atten-
tion, processing speed, set shifting, and verbal fluency [32,
36, 37]. The most significant deficit among adolescents with
attenuated positive symptoms was obtained in receptive lan-
guage; these findings correspondwith the study on childhood
developmental deficits preceding schizophrenia [38] and
suggest language processing as one of the earliest emerging
alterations related to vulnerability to psychosis. Additionally,
several authors observed spatial memory and visual-spatial
processing deficits in UHR subjects compared to controls.
Moreover, it has been shown that individuals who later
develop a psychotic disorder performed more poorly on
spatial working memory tests [39].
At a group level, the range of cognitive deficits in UHR
subjects seems to have an intermediate position between
healthy comparison subjects and patients with first episode of
schizophrenia [15, 40]. Notably, Eastvold et al. [40] compared
the baseline neurocognitive profiles of individuals at risk who
later converted to psychosis (true prodromals) to those indi-
viduals who have experienced their first episode of psychosis
and healthy comparison subjects. They showed that the true
prodromals had the largest effect sizes versus the healthy
comparison subjects in the verbal episodic memory scores
and general intellectual functioning of the same magnitude
as it was detected in the first episode sample. Jahshan et al.
[41] also reported the significant time effects of executive
functioning, processing speed, verbal learning, and general
intelligence between the groups of UHR individuals, first
episode patients, andnormal controls.These results are in line
with the other reports which stated verbal learning deficits at
baseline assessment as well as the decline in verbal memory
and general intellectual functioning in UHR subjects who
later converted to psychosis. This cognitive decline was
consistent with theworsening or themanifestation of the psy-
chotic symptoms. However, impairments in attention seem
not to have a predictive value in psychosis development [42–
44].
Relatively fewer longitudinal studies on neuropsycholog-
ical functioning in at-risk subjects have revealed an associ-
ation between greater cognitive impairment at baseline and
subsequent conversion to psychosis [45, 46], specifically, the
decline in verbal abilities, memory, and intellectual functions
[42, 43, 47, 48]. Niendam et al. [49] found that high-risk
subjects improved over an 8-month period on measures of
information processing speed, as well as visual and verbal
learning/memory. However, the study of Hawkins et al. [50]
in which participants were assessed at entry and at 6 and 12
months failed to prove a decline of the cognitive functioning
during the period of transition to psychosis.
Regarding the stability of cognitive dysfunction in the
groups of prodromals, first-episode patients, and controls,
the results of the longitudinal study showed deterioration
in working memory and processing speed in first-episode
patients and UHR subjects who later converted to psychosis
[41]. This is consistent with a cross-sectional investigation of
neurocognitive functioning in patients classified as being in
various stages of prodrome and postonset psychosis, which
reported the increase of neurocognitive deficits at each “stage”
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of the illness [51]. Thus, cognitive functions do not follow a
one-dimensional trajectory in schizophrenia but rather vary
by cognitive domain and position in the course of the illness.
Not all studies have reported neurocognitive decline
during the prodromal stage or simply a link between neu-
rocognitive changes and conversion to psychosis [50, 52].
Some of these inconsistenciesmay be due to differences in the
definition of the prodrome of schizophrenia. In studies where
early and late prodromals were separated, significant differ-
ence in executive functioning with a higher percentage of
perseverative and nonperseverative errors inWisconsin Card
Sorting Test (WCST)was obtained [53]. Frommann et al. [54]
have recently reported that subjects in the late prodromal
phase are impaired in all neurocognitive domains, whereas
individuals in the early prodromal phase had a specific deficit
only in processing speed/executive control.
Furthermore, these early changes in overall neurocogni-
tive functioning seem to occur in synergy with changes in
positive symptom severity in the UHR group.The substantial
improvement in clinical symptoms and Global Assessment
of Functioning Scale (GAF) scores over time in the UHR
grouphighlights that the at-risk state can be transient inmany
young people; thus, cognitive changes may be difficult to
detect [41]. In contrast with investigations showing a decline
in IQ prior to the schizophrenia onset [55], a significant
proportion of UHR subjects demonstrated an improvement
in general intelligence over the 6-month followup.
Functional imaging studies in at-risk individuals while
performing cognitive tasks also underline altered activations
of brain areas which are prone to structural deficits [56].
Voxel-wise meta-analysis of fMRI studies in individuals
at clinical high risk for psychosis revealed reduced blood
oxygenation level-dependent response (BOLD) in the left
inferior frontal gyrus and in a cluster spanning the bilateral
medial frontal gyrus, bilateral superior frontal gyrus, and the
left anterior cingulate [57].
Several systematic reviews and meta-analysis have dem-
onstrated a relationship between standardized neurocogni-
tive tests on attention, memory, and problem-solving as well
as overall measures of cognition with the variety of parame-
ters of social functioning and functional outcomes [58, 59]. It
has also been shown that cognitive deficit could impede the
acquisition of elementary social skills in schizophrenia [60,
61]. Moreover, neurocognitive impairment can negatively
mediate social cognition and thereby exert a negative influ-
ence on functional outcomes [62]. In regard to the prodromal
stage, clinical high-risk individuals display not only cognitive
but also functional decline; notably, in the individuals with
attenuated positive symptoms impaired processing speed is
related to the difficulties in social and role functioning [63].
In sum, cognitive deficits occur early in the prepsychotic
phase of schizophrenia, mostly grasping memory, executive
functioning, and general intellectual abilities although being
less prominent as in themanifestation of psychosis. Receptive
language and spatial memory functions seem to be prone to
further deterioration which might have a predictive value in
the transition to psychosis and hence require special focus in
the preventive and treatment strategies.
3. Cognitive Remediation and Its Effectiveness
Cognitive remediation (CR) represents a broad set of activ-
ities and exercises that aim to restore or improve cognitive
functioning, that is, attention, working memory, planning,
and executive functions by stimulating new learning and
facilitating social functioning. The ultimate goal of the
intervention though is a generalization of the obtained skills
in the habitual community setting. To date, several mod-
els of cognitive remediation can be assessed. Some mod-
els emphasize training of isolated cognitive skills (verbal and
visual working memory, executive function, attention, and
processing speed), so-called drill practice using a number of
trials of the same exercise to facilitate learning; other mod-
els offer cognitive training in conjunction with vocational
training and social skills training [64].The strategy-coaching
approach uses cognitive-training exercises in a group setting
and relies on development and maintenance of motivation in
participants.
The existing techniques of cognitive remediation com-
bine cognitive and specific compensatory skills trainings
which are addressed in accordance with the initial goal of the
remediation therapy. Cognitive training, either computerized
using CogRehab software [65], or therapist guided pen and
pencil training includes tasks in the following cognitive
domains: verbal and visual memory, language, visuo-motor
skills, orientation, vigilance, processing speed, and so forth.
The training is carried out by patients usually for 1-2 hours
per day several times a week and integrated with weekly ther-
apy sessions. The neuropsychological educational approach
to rehabilitation (NEAR) method uses a strategy-coaching
approach. After the computerized session of the training,
participants elaborate and discuss in a small group the
strategies that they have learned while practicing cognitive
tasks and how these skills may be transposed to real life activ-
ities [66]. In neurocognitive enhancement therapy (NET)
computerized cognitive remediation is used along with the
vocational rehabilitation programs [67]. Cognitive enhance-
ment therapy (CET) includes small-group sessions with a
specific emphasis on social cognition and also comprises
supportive therapy [68]. Pair cognitive remediation embodies
cognitive training and a supported employment program
aiming to facilitate social recovery in schizophrenia [69].The
number of sessions varies in different cognitive remediation
approaches.
Recently, new programs exploiting cognitive remediation
strategies have appeared.Thus, Cognitive adaptation training
(CAT) is a home delivered cognitive rehabilitation strategy
which is designed to train cognition in order to offer
solutions to the daily life problems, specific and concrete
to each individual [70]. Another intriguing approach is the
brain fitness program (BFP), a drill practice method, used
in order to improve brain plasticity. The aim of BFP is to
restore and amplify auditory perception and working mem-
ory processing through six exercises of increasing com-
plexity. It starts with the mastering of the formants in
speech (such as phonemes, words, and sentences), continuing
with the remembering of the sequence of verbal instructions,
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and ending with the processing of real world scenarios of
conversational narratives [71].
Several meta-analyses have been carried out to evaluate
the effectiveness of cognitive remediation in schizophrenia
[72, 73]. McGurk et al. [73] included 26 randomized control
trials showing a medium range of the effect size of 6 from 7
estimated cognitive functions, specifically in attention, speed
of processing, executive functioning, verbal working mem-
ory, verbal learning and memory, and visual learning and
memory. The effects of cognitive remediation were similar
across the 26 studies included in the analysis regardless of
the duration of training and training methods, age of the
participants, inpatient or outpatient provision of CR, and
other complimentary rehabilitation programs. Follow-up
data analysis of 6 studies also showed significant improve-
ment of the global cognitive performance with the effect size
0.56 after initial treatment and 0.66 after 8 month followup
[74]. It was also indicated that compared to drill and practice
alone approaches, the strategies using coaching were less
effective (effect size 0.48 versus 0.23) and longer programs
were more beneficial for patients than shorter programs
regardless of the type of the training (effect size 0.57 versus
0.29). In a recent study, Bowie et al. also indicated a favorable
effect of combined treatment using cognitive remediation
and functional skills training on cognitive functioning but
not cognitive remediation alone in schizophrenia outpa-
tients. Along with cognitive improvement, social competence
increase was more durable with combined treatment during
12 months followup [75].
Taking into account cognitive heterogeneity in schizo-
phrenia, it is crucial to identify whether particular groups
of patients benefit from cognitive remediation therapy. The
recent meta-analysis by Wykes et al. [76] aimed to demon-
strate not only the effectiveness of CR but also to determine
the way in which these programs help in different categories
of patients, thus, indicating more malleable cognitive targets.
Interestingly, cognitive impairment as an entry criterion
did not affect cognition outcomes; larger effect sizes were
detected in studies which included clinically stable patients
with schizophrenia and schizoaffective disorder. Age seemed
not to be a predictor and although greater numbers of symp-
toms were associated with smaller effect sizes, patients still
benefitted from CR. Moreover, the results of the meta-
analysis suggests that most effective programs combine CR
with other rehabilitationmodules.Thus, strategic approaches
rather than drill practice favored better outcomes possibly
due to the reciprocal boosting effects which contribute to
transferring of the gained benefits into everyday life. It was
also shown that cognitive remediation has a consistent effect
on improving of functioning [73]. The impact of CR on
functional outcomes was significantly greater when it was
combinedwith psychosocial rehabilitation, therefore, provid-
ing a synergic effect [73, 76].
Nevertheless, the utilization of the computerized cog-
nitive remediation training has not provided any evidence
of the efficacy of the intervention in stable patients with
schizophrenia [77, 78]. Although there has been a significant
improvement of auditory processing speed, this effect did
not lead to improved overall cognitive performance. One can
hypothesize that social interaction in a group settingmight be
beneficial for obtaining and consolidating of cognitive skills.
Furthermore, there is still an open question how the obtained
skills can be generalized into the habitual community setting.
So far, longitudinal studies have failed to corroborate the
constant gains of cognitive remediation techniques in the
everyday life of patients. Thus, meta-analysis demonstrates a
small to moderate effect of cognitive rehabilitation on cogni-
tive outcomes at the followup assessment in individuals with
a diagnosis of schizophrenia [79].
The recent study of Penades et al. [80] showed that
cognitive remediation therapy in schizophrenia patients may
have a positive effect on the brain plasticity. Specifically, the
authors demonstrated that brain network activation sig-
nificantly changed and even tended to normalize during
application of strategy-learning based treatment. Besides,
there has been an increase of fractional anisotropy in the cor-
pus callosum meaning potential improvement of interhemi-
spheric information transfer. These data positively correlated
with the parameters of cognitive functioning and functional
outcomes.
Cognitive remediation has started to be applied in ultra-
high risk individuals with the aim of reducing and prevent-
ing the progression of schizophrenia. Meanwhile, only two
studies have shown the beneficial effect of remediation on
cognition in UHR individuals, although within the frame-
work of an integrated psychological intervention [81]. In a
study using computerized CogPack [82] the high-risk group
displayed considerable gains in improving of cognitive skills,
specifically in verbal memory in contrast to the patients
with full psychosis. Furthermore, there is evidence from a
study by Bechdolf et al. [83], who showed a significantly
lower rate of transition to psychosis in the individuals that
have been involved in integrated psychosocial interventions,
which include cognitive remediation strategies.
Thus, the variety of techniques of cognitive remediation,
blended with social skills training seems to be of the greatest
utility in cognitive improvement in patients with psychosis,
being particularly beneficial for clinically stable patients with
schizophrenia and schizoaffective disorder. CR is becoming
a useful tool in preventing cognitive decline in UHR indi-
viduals and boosting their social functioning. However, the
durability of the gained positive effect of CR on cognition
and social functioning must still be addressed in further
longitudinal studies.
4. Future Challenges for
Cognitive Remediation
A notion that cognitive deficits are nuclear and irremediable
is being challenged by the evidence of cognitive improvement
following medication use and cognitive remediation therapy
[84]. Cognitive impairment can still be moderate in the early
stages of the schizophrenia prodrome and this supports cur-
rent efforts to intervene in the early course of the illness [85].
However, the multifaceted nature of cognitive dysfunction
raises the possibility of selecting more specific treatment
targets in the future, specifically in slowing down the decline
in working memory and executive functioning, improving
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the processing speed before the onset of psychosis [86]. A
widespread cognitive impairment should not be assumed in
all individuals with schizophrenia, as cognitive heterogeneity
is likely to be present at the onset as well as throughout the
illness. Although cognitive remediation may not contribute
to the immediate gains in cognitive functioning, it could facil-
itate the retention of the improvements following treatment
during all stages of schizophrenia.
It continues to be an aim of detection of individuals who
are at ultrahigh risk of psychotic illness to treat them with
cognitive techniques in order to prevent the further devel-
opment of psychotic illness. The recent EDIE study has been
reported as not significantly reducing transition to psychosis
or symptom-related distress but has reportedly reduced the
severity of psychotic symptoms in young people at high risk
[87]. It could be that the use of the cognitive remediation
techniques described may produce different results. Further-
more, while we continue to search for a new generation of
antipsychotic drugs which will positively affect cognition, it
seems probable that neurocognitive testing will begin to have
a key role in the assessment of individuals with first episode
or late prodromal psychosis, as a measurable correlate of the
gray matter loss in these phases of the illness.
In conclusion, the use of cognitive remediation could be
an important part of treatment of the ultrahigh risk group
in order to assist with changing cognitive deficits. Thus, a
set of interventions, most likely combined therapy which
incorporates cognitive remediation and social skills training,
would be beneficial in slowing the progression of cognitive
decline in UHR individuals. Moreover, given the risk of
negative impact of cognitive deficits and social functioning in
the prepsychotic stage, it is important to optimize the therapy
by offering it over an adequate time. Such a comprehensive
approach could maintain functional gains and preserve the
opportunity to achieve functional improvement during the
early stages of schizophrenia.
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